Invention Grant
- Patent Title: Roflumilast prodrugs
-
Application No.: US15502793Application Date: 2015-10-21
-
Publication No.: US09969688B2Publication Date: 2018-05-15
- Inventor: Atsushi Sonobe , Takashi Yasukochi , Yasunori Takada , Kenji Atarashi , Motohiro Suzuki , Shinichi Yokota
- Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
- Applicant Address: JP Tosu-shi, Saga
- Assignee: HISAMITSU PHARMACEUTICAL CO., INC.
- Current Assignee: HISAMITSU PHARMACEUTICAL CO., INC.
- Current Assignee Address: JP Tosu-shi, Saga
- Agency: Sughrue Mion, PLLC
- Priority: JP2014-217205 20141024
- International Application: PCT/JP2015/079689 WO 20151021
- International Announcement: WO2016/063906 WO 20160428
- Main IPC: C07D213/75
- IPC: C07D213/75

Abstract:
The present invention provides a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R is a hydrogen atom, a C1-6 alkyl group optionally substituted with one or more hydroxyl groups, a C1-6 alkoxy group, or a cyano group.
Public/Granted literature
- US20170233343A1 PRODRUG Public/Granted day:2017-08-17
Information query
IPC分类: